EC Number | Metals/Ions | Comment | Organism | Structure |
---|---|---|---|---|
1.1.1.189 | Zn2+ | 1.9 g-atoms per mol enzyme | Sus scrofa |
EC Number | Molecular Weight [Da] | Molecular Weight Maximum [Da] | Comment | Organism |
---|---|---|---|---|
1.1.1.189 | 32000 | - |
gel filtration, 4 isoforms | Sus scrofa |
1.1.1.189 | 34000 | - |
gel filtration, 4 isoforms | Homo sapiens |
1.1.1.189 | 35000 | - |
alpha, 1 * 35000, SDS-PAGE | Sus scrofa |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
1.1.1.189 | Homo sapiens | - |
- |
- |
1.1.1.189 | Sus scrofa | - |
- |
- |
EC Number | Purification (Comment) | Organism |
---|---|---|
1.1.1.189 | - |
Homo sapiens |
1.1.1.189 | - |
Sus scrofa |
EC Number | Source Tissue | Comment | Organism | Textmining |
---|---|---|---|---|
1.1.1.189 | kidney | - |
Homo sapiens | - |
1.1.1.189 | kidney | - |
Sus scrofa | - |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
1.1.1.189 | (5Z,13E)-(15S)-11alpha,15-dihydroxy-9-oxoprosta-5,13-dienoate + NAD(P)+ | - |
Homo sapiens | (5Z,13E)-11alpha-hydroxy-9,15-dioxoprosta-5,13-dienoate + NAD(P)H | - |
? | |
1.1.1.189 | (5Z,13E)-(15S)-11alpha,15-dihydroxy-9-oxoprosta-5,13-dienoate + NAD(P)+ | - |
Sus scrofa | (5Z,13E)-11alpha-hydroxy-9,15-dioxoprosta-5,13-dienoate + NAD(P)H | - |
ir | |
1.1.1.189 | (5Z,13E)-(15S)-9alpha,11alpha,15-trihydroxyprosta-5,13-dienoate + NADP+ | - |
Homo sapiens | (5Z,13E)-(15S)-11alpha,15-dihydroxy-9-oxoprosta-5,13-dienoate + NADPH + H+ | - |
r | |
1.1.1.189 | (5Z,13E)-(15S)-9alpha,11alpha,15-trihydroxyprosta-5,13-dienoate + NADP+ | enzyme is pro(S) stereo selective with regard to hydrogen transfer from NADPH | Sus scrofa | (5Z,13E)-(15S)-11alpha,15-dihydroxy-9-oxoprosta-5,13-dienoate + NADPH + H+ | - |
r | |
1.1.1.189 | (5Z,13E)-(15S)-9alpha,11alpha,15-trihydroxyprosta-5,13-dienoate + NADP+ | - |
Homo sapiens | (5Z,13E)-9alpha,11alpha-dihydroxy-15-oxoprosta-5,13-dienoate + NADPH + H+ | - |
? | |
1.1.1.189 | (5Z,13E)-(15S)-9alpha,11alpha,15-trihydroxyprosta-5,13-dienoate + NADP+ | - |
Sus scrofa | (5Z,13E)-9alpha,11alpha-dihydroxy-15-oxoprosta-5,13-dienoate + NADPH + H+ | - |
ir | |
1.1.1.189 | (5Z,13E)-(15S)-9alpha,15-dihydroxy-11-oxoprosta-5,13-dienoate + NADP+ | - |
Homo sapiens | (5Z,13E)-9alpha-hydroxy-11,15-dioxoprosta-5,13-dienoate + NADPH | - |
? | |
1.1.1.189 | (5Z,13E)-(15S)-9alpha,15-dihydroxy-11-oxoprosta-5,13-dienoate + NADP+ | - |
Sus scrofa | (5Z,13E)-9alpha-hydroxy-11,15-dioxoprosta-5,13-dienoate + NADPH | - |
ir |
EC Number | Subunits | Comment | Organism |
---|---|---|---|
1.1.1.189 | monomer | alpha, 1 * 34000, SDS-PAGE | Homo sapiens |
1.1.1.189 | monomer | alpha, 1 * 35000, SDS-PAGE | Sus scrofa |
EC Number | Cofactor | Comment | Organism | Structure |
---|---|---|---|---|
1.1.1.189 | NAD+ | preferential 15-keto prostaglandin F2alpha formation | Sus scrofa | |
1.1.1.189 | NADPH | - |
Homo sapiens | |
1.1.1.189 | NADPH | - |
Sus scrofa |